Enhancing Sunscreens: HPβCD Improves Ferulic Acid Efficacy
Researchers from Brazil 🇧🇷 developed a HPβCD-based system to improve the stability, safety, and antioxidant activity of ferulic acid for
Enhancing Sunscreens: HPβCD Improves Ferulic Acid Efficacy
Researchers from Brazil 🇧🇷 developed a HPβCD-based system to improve the stability, safety, and antioxidant activity of ferulic acid for
Protein Folding with Ionic Liquids and β-CD
Protein refolding and unfolding assays are essential for understanding of protein conformational transitions, assessing the stability of proteins, particularly their
CD-enhanced drug permeation through biomembranes
CDs enhance drug permeation across biomembranes predominantly through physicochemical and mass-transfer mechanisms rather than by disrupting membrane integrity or altering
Special issue: Starch-Derived Functional Polymers: Cyclodextrins, Dextrins, and Advanced Gels from Synthesis to Smart Applications
Guest editors: Dr. Gjylije Hoti & Dr. Fabrizio CalderaDepartment of Drug Science and Technology, Department of Chemistry, University of Turin,
HPBCD–myrrh oil inclusion complex: enhancing solubility and antibacterial activity
Poor aqueous solubility limits the use of myrrh oil in antibacterial aqueous formulations. Here, a hexane extract of Commiphora myrrh
Impact of Threading State on the Mechanics of γ-Cyclodextrin–Pyrene Gels
Researchers from the United States developed γCD-pyrene gels with different network architectures by controlling whether the CD-based crosslinkers were singly
New Trends in Cyclodextrins Technology for Pharmaceutical
A new book is expected to be published on Nov. 1, 2026 by Elsevier with subtitle: Innovations Based on Cyclodextrins
The Cyclodextrin Wall of Pride: Who Are the Top-Cited Cyclodextrin Scientists?
Cyclodextrins have been in the focus of chemistry for decades. Behind the knowledge of cyclodextrin science are a few hundred
Over 70,000 hits in Scopus for “cyclodextrin” keyword
Although discovered over 130 years ago, cyclodextrin research continues to flourish, as evidenced by data from Elsevier’s Scopus database. The
Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC) concluded
The global, double-blind, placebo-controled Phase 3 TransportNPC™ study (CTD-TCNPC-301) enroled 94 patients with NPC, ranging in age from 3 to